New chemical and biological entities approved by the Therapeutic Goods Administration, January 1, 2005 to May 7, 2024

This dataset includes information on drug approvals by the Australian Therapeutic Goods Administration (TGA) from 2005 to May 2024. Generic, brand name, indication, approval pathway (when applicable), and date of approval are included. In addition, therapeutic ratings from the Patented Medicines Prices Review Board (PMPRB, Canada), Prescrire, Haute Autorité de Santé (HAS, France), and the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG, Germany), and Pharmaceutical Benefits Schedule (PBS) listing status have been included.

本数据集包含2005年至2024年5月期间澳大利亚治疗用品管理局（TGA）批准的药物相关信息，涵盖通用名、品牌名、适应症、批准途径（如适用）及批准日期。此外，还纳入了加拿大专利药品价格审查委员会（PMPRB）、Prescrire、法国高级卫生管理局（HAS）、德国卫生保健质量与效率研究所（IQWiG）的治疗评级，以及药品福利计划（PBS）的列入状态。